ADVIL PM is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Wyeth Consumer Healthcare Llc. The primary component is Diphenhydramine Citrate; Ibuprofen.
| Product ID | 0573-0164_11aae8eb-fa5a-4645-96eb-fa9f24e39535 |
| NDC | 0573-0164 |
| Product Type | Human Otc Drug |
| Proprietary Name | ADVIL PM |
| Generic Name | Diphenhydramine Citrate And Ibuprofen |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021394 |
| Labeler Name | Wyeth Consumer Healthcare LLC |
| Substance Name | DIPHENHYDRAMINE CITRATE; IBUPROFEN |
| Active Ingredient Strength | 38 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2005-12-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-09-14 |
| Marketing End Date | 2018-09-14 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2017-03-17 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2017-03-17 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-09-30 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-21 |
| Marketing Category | NDA |
| Application Number | NDA021394 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2005-12-21 |
| Ingredient | Strength |
|---|---|
| DIPHENHYDRAMINE CITRATE | 38 mg/1 |
| SPL SET ID: | 7586892a-32c2-a43f-e053-2991aa0a4680 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| UPC Code | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0573-0164 | ADVIL PM | diphenhydramine citrate and ibuprofen |
| 0573-0167 | ADVIL PM | diphenhydramine HCl, ibuprofen |
| 66715-9733 | Advil PM | Ibuprofen and Diphenhydramine citrate |
| 67751-147 | Advil PM | DIPHENHYDRAMINE CITRATE, IBUPROFEN |
| 29485-6644 | ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated | Advil PM |
| 29485-7008 | ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated | Advil PM |
| 29485-7088 | ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated | Advil PM |
| 29485-7937 | ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated | Advil PM |
| 41520-050 | Care One Ibuprofen PM | diphenhydramine citrate and ibuprofen |
| 55910-050 | dg health Ibuprofen pm | diphenhydramine citrate and ibuprofen |
| 30142-050 | ibuprofen pm | diphenhydramine citrate and ibuprofen |
| 59779-050 | ibuprofen pm | diphenhydramine citrate and ibuprofen |
| 49348-873 | sunmark ibuprofen pm | diphenhydramine citrate and ibuprofen |
| 36800-050 | Topcare Ibuprofen PM | diphenhydramine citrate and ibuprofen |
| 11673-050 | up and up ibuprofen pm | diphenhydramine citrate and ibuprofen |